ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
19.92 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 15.74 Today|||52-Week Range 41.20 | -33.84% Year-to-Date |
Latest ACAD News | Press Releases
No recent news for ACADIA Pharmaceuticals Inc.
Today’s Trading
Previous close | 19.90 |
Today’s open | 19.95 |
Day’s range | 19.61 - 20.44 |
Volume | 1,738,371 |
Average volume (3 months) | 2,320,276 |
Market cap | $3.2B |
Data as of 4:00pm ET, 04/23/2018
Growth & Valuation
Earnings growth (last year) | -0.85% |
Earnings growth (this year) | +22.19% |
Earnings growth (next 5 years) | -94.00% |
Revenue growth (last year) | +620.68% |
P/E ratio | NM |
Price/Sales | 29.56 |
Price/Book | 9.40 |
Competitors
Today’s change | Today’s % change | |
---|---|---|
TAROTaro Pharmaceutical ... | +0.38 | +0.38% |
AKRXAkorn Inc | -6.65 | -33.76% |
---- | ||
MNKMallinckrodt Plc | -0.69 | -5.01% |
Data as of 4:01pm ET, 04/23/2018
Financials
Next reporting date | May 8, 2018 |
EPS forecast (this quarter) | -$0.52 |
Annual revenue (last year) | $124.9M |
Annual profit (last year) | -$289.4M |
Net profit margin | -231.71% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Stephen R. Davis |
Senior VP-Strategy & Technology Operations Bob Mischler |
Corporate headquarters San Diego, California |
Forecasts
